Cyxtera Results Presentation Deck
Q1 2023 Results
Cyxtera
($ in Millions)
Recurring Revenue
Non-Recurring Revenue
Total Revenue
Cost of Revenue
As a % of Revenue
Gross Profit
% Margin
Total SG & A
As a % of Revenue
Other (1)
EBITDA
% Margin
Transaction Adjustments
Transaction Adjusted EBITDA (2)
% Margin
Rent (net of adjustments)
Transaction Adjusted EBITDAR (³)
% Margin
Capital Expenditures
As a % of Revenue
Q1 '23
$188.4
8.3
$196.7
$103.8
52.8%
$92.9
47.2%
$42.1
21.4%
$282.7
($231.9)
(117.9%)
$295.2
$63.3
32.2%
$15.4
$78.7
40.0%
$26.4
13.4%
Q1 '22
$173.7
8.7
$182.4
$98.0
53.7%
$84.4
46.3%
$31.3
17.1%
($10.5)
$63.6
34.9%
($5.0)
$58.6
32.1%
$15.7
$74.3
40.7%
$34.0
18.6%
(1) Q1 23 includes $278.2M Goodwill Impairment and $4.5 in restructuring, impairment, site closures and related cost. Q1 22 includes $11.8M benefit related to change in fair value of derivative liabilities, offset by $1.3M in restructuring, impairment, site closures and
related cost.
(2) Earnings Before Interest, Taxes, Depreciation & Amortization
(3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent
YoY
Change
8.5%
-5.4%
7.8%
5.9%
(97 bps)
10.1%
97 bps
34.8%
428 bps
ΝΑ
-464.8%
(15,277 bps)
8.0%
5 bps
5.9%
(73 bps)
-22.2%
(519 bps)
7View entire presentation